F.W. Bertelsmann

1.1k total citations
16 papers, 515 citations indexed

About

F.W. Bertelsmann is a scholar working on Pathology and Forensic Medicine, Neurology and Physiology. According to data from OpenAlex, F.W. Bertelsmann has authored 16 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 6 papers in Physiology. Recurrent topics in F.W. Bertelsmann's work include Pain Mechanisms and Treatments (5 papers), Multiple Sclerosis Research Studies (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). F.W. Bertelsmann is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Multiple Sclerosis Research Studies (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). F.W. Bertelsmann collaborates with scholars based in Netherlands, Norway and Nepal. F.W. Bertelsmann's co-authors include J.J. Heimans, A. C. Van Loenen, Chris H. Polman, E.A. van der Veen, J.C. Koetsier, H.A.M. van Diemen, J. A. Schouten, Eckhard Weber, J. J. P. Nauta and CH Polman and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of the Neurological Sciences.

In The Last Decade

F.W. Bertelsmann

16 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.W. Bertelsmann Netherlands 11 216 199 134 73 53 16 515
H. Brunnschweiler Switzerland 6 316 1.5× 177 0.9× 122 0.9× 57 0.8× 97 1.8× 7 598
A. Moglia Italy 14 89 0.4× 231 1.2× 226 1.7× 143 2.0× 63 1.2× 69 691
G.F. Sau Italy 12 187 0.9× 183 0.9× 30 0.2× 63 0.9× 24 0.5× 28 491
Wolfgang Hamann United Kingdom 15 94 0.4× 66 0.3× 299 2.2× 83 1.1× 59 1.1× 33 766
Niels Hansen Germany 11 170 0.8× 274 1.4× 167 1.2× 50 0.7× 56 1.1× 65 567
Stasha Gominak United States 8 93 0.4× 113 0.6× 54 0.4× 71 1.0× 139 2.6× 10 453
Sandip Shaunak United Kingdom 13 36 0.2× 206 1.0× 107 0.8× 71 1.0× 87 1.6× 21 552
Harry Kerasidis United States 5 324 1.5× 89 0.4× 51 0.4× 180 2.5× 58 1.1× 5 490
Keith R. Hildebrand United States 17 104 0.5× 81 0.4× 285 2.1× 156 2.1× 109 2.1× 27 860
D. Soragna Italy 11 98 0.5× 133 0.7× 32 0.2× 95 1.3× 50 0.9× 17 474

Countries citing papers authored by F.W. Bertelsmann

Since Specialization
Citations

This map shows the geographic impact of F.W. Bertelsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.W. Bertelsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.W. Bertelsmann more than expected).

Fields of papers citing papers by F.W. Bertelsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.W. Bertelsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.W. Bertelsmann. The network helps show where F.W. Bertelsmann may publish in the future.

Co-authorship network of co-authors of F.W. Bertelsmann

This figure shows the co-authorship network connecting the top 25 collaborators of F.W. Bertelsmann. A scholar is included among the top collaborators of F.W. Bertelsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.W. Bertelsmann. F.W. Bertelsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gerritsen, Annette, Henrica C. W. de Vet, R. J. P. M. Scholten, et al.. (2002). Betere klinische effecten op carpale-tunnelsyndroom van operatie dan van spalkbehandeling; resultaten van een gerandomiseerd klinisch onderzoek. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(45). 2153–2156. 3 indexed citations
2.
Huisman, Holger, et al.. (2001). Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury. Journal of Neurology. 248(8). 665–671. 41 indexed citations
3.
Kets, C. Marleen, Monique E. van Leerdam, Wim H. van Brakel, W. Devillé, & F.W. Bertelsmann. (1996). Reference values for touch sensibility thresholds in healthy Nepalese volunteers. Leprosy Review. 67(1). 28–38. 29 indexed citations
4.
Polman, Chris H., F.W. Bertelsmann, Reneé de Waal, et al.. (1994). 4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis. Archives of Neurology. 51(11). 1136–1139. 47 indexed citations
5.
Emmen, Harry, et al.. (1994). The effects of 4‐aminopyridine on cognitive function in patients with multiple sclerosis. Neurology. 44(9). 1701–1701. 68 indexed citations
6.
Nauta, J., et al.. (1993). 多発性硬化症患者における4-アミノピリジン 効果および安全性に関連した用量および血清中濃度. Clinical Neuropharmacology. 16(3). 195–204. 3 indexed citations
7.
Diemen, H.A.M. van, Chris H. Polman, J. J. P. Nauta, et al.. (1993). 4-Aminopyridine induces functional improvement in multiple sclerosis patients: A neurophysiological study. Journal of the Neurological Sciences. 116(2). 220–226. 45 indexed citations
8.
Diemen, H.A.M. van, Chris H. Polman, J.C. Koetsier, et al.. (1993). 4-Aminopyridine in Patients with Multiple Sclerosis. Clinical Neuropharmacology. 16(3). 195–204. 69 indexed citations
9.
Bertelsmann, F.W., et al.. (1991). Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis. Journal of the Neurological Sciences. 102(1). 25–31. 10 indexed citations
10.
Drukarch, Benjamin, et al.. (1991). Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study. Acta Neurologica Scandinavica. 84(6). 483–486. 5 indexed citations
11.
Faes, Theo J. C., et al.. (1990). Quantitation of skin vasomotor control in normal subjects and in diabetic patients with autonomic neuropathy. Journal of Neurology. 237(8). 457–460. 5 indexed citations
12.
Scheltens, Philip, Curt W. Burger, Jaap Valk, & F.W. Bertelsmann. (1989). Anterolateral lumbar meningocele presenting as an ovarian cyst, in a patient with neurofibromatosis. Clinical Neurology and Neurosurgery. 91(4). 351–354. 4 indexed citations
13.
Bertelsmann, F.W., et al.. (1987). Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.. Journal of Neurology Neurosurgery & Psychiatry. 50(10). 1337–1341. 26 indexed citations
14.
Heimans, J.J., et al.. (1986). Large and small nerve fiber function in painful diabetic neuropathy. Journal of the Neurological Sciences. 74(1). 1–9. 47 indexed citations
15.
Bertelsmann, F.W., et al.. (1986). Comparison of Hoffmann reflex with quantitative assessment of cutaneous sensation in diabetic neuropathy. Acta Neurologica Scandinavica. 74(2). 121–127. 17 indexed citations
16.
Bertelsmann, F.W., J.J. Heimans, Eckhard Weber, E.A. van der Veen, & J. A. Schouten. (1985). Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy.. Journal of Neurology Neurosurgery & Psychiatry. 48(7). 686–690. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026